000 | 01830 a2200541 4500 | ||
---|---|---|---|
005 | 20250517070913.0 | ||
264 | 0 | _c20160927 | |
008 | 201609s 0 0 eng d | ||
022 | _a2376-1032 | ||
024 | 7 |
_a10.18553/jmcp.2015.21.12.1195 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTan, Eleonora | |
245 | 0 | 0 |
_aGeographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes. _h[electronic resource] |
260 |
_bJournal of managed care & specialty pharmacy _cDec 2015 |
||
300 |
_a1195-202 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministrative Claims, Healthcare |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
650 | 0 | 4 | _aCommerce |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHealth Status Disparities |
650 | 0 | 4 | _aHealthcare Disparities |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
650 | 0 | 4 | _aInsurance, Pharmaceutical Services |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMedicaid |
650 | 0 | 4 | _aMedicare |
650 | 0 | 4 | _aMedication Adherence |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPractice Patterns, Physicians' |
650 | 0 | 4 | _aResidence Characteristics |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aUnited States _xepidemiology |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aYang, Wenya | |
700 | 1 | _aPang, Bo | |
700 | 1 | _aDai, Mingliang | |
700 | 1 | _aLoh, F Ellen | |
700 | 1 | _aHogan, Paul | |
773 | 0 |
_tJournal of managed care & specialty pharmacy _gvol. 21 _gno. 12 _gp. 1195-202 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18553/jmcp.2015.21.12.1195 _zAvailable from publisher's website |
999 |
_c25553264 _d25553264 |